Genetics and epigenetics

Subspecialties Hematology

12/26/2022 | George Francis Lee | 3 min read

What are the latest developments in technology and techniques for hematopathology?

Subspecialties Hematology

12/20/2022 | George Francis Lee | 3 min read

A molecular missive on research presented at American Society of Hematology Meeting and Exposition 2022

Subspecialties Microbiology and immunology

12/15/2022 | Marwan Alsarraj | 4 min read

In the deep waters of gene therapy products, does a potential danger lie below the surface?

Subspecialties Hematology

12/13/2022 | George Francis Lee | 3 min read

A brisk jog through some of hematopathology’s most interesting research stories

Subspecialties Oncology

12/06/2022 | Sponsored by Thermo Fisher Scientific | 4 min read

Lung cancer patients can’t always wait for treatment – so rapid in-house NGS can facilitate precision therapy fast

Diagnostics Omics

12/02/2022 | Stephen Kingsmore | 15 min read

Rapid, reliable, widespread whole genome sequencing could shorten the rare disease diagnostic odyssey and improve patients’ lives

Diagnostics Oncology

11/24/2022 | Liv Gaskill | 3 min read

Homologous recombination deficiency is a crucial predictive biomarker in certain cancer types – and it’s time to get on board

Diagnostics Genetics and epigenetics

11/21/2022 | George Francis Lee | 2 min read

The world of cancer genetics is getting bigger… so we bring you the latest news and research in molecular oncology

Subspecialties Oncology

11/15/2022 | George Francis Lee | 2 min read

Like the progression of the disease itself, the growth of knowledge around chronic lymphocytic leukemia is slow, but steady

Diagnostics Genetics and epigenetics

11/10/2022 | Sponsored by QIAGEN | 6 min read

The need for molecular testing in NSCLC patients is growing – and QIAGEN can help you meet it